Cargando…

Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer

Bladder cancer (BC) is the ninth most common cancer worldwide. Radical cystectomy (RC) with neoadjuvant chemotherapy (NAC) is recommended for muscle-invasive BC. The challenge of the neoadjuvant approach relates to challenges in selection of patients to chemotherapy that are likely to respond to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tervahartiala, Minna, Taimen, Pekka, Mirtti, Tuomas, Koskinen, Ilmari, Ecke, Thorsten, Jalkanen, Sirpa, Boström, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627306/ https://www.ncbi.nlm.nih.gov/pubmed/28978923 http://dx.doi.org/10.1038/s41598-017-12892-5

Ejemplares similares

Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer
por: Blomqvist, Matias, et al.
Publicado: (2021)

Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer
por: Boström, Minna M., et al.
Publicado: (2015)

(11)C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)
por: Salminen, Antti, et al.
Publicado: (2018)

Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression
por: Saarinen, Irena, et al.
Publicado: (2015)

Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy
por: Boström, Peter J., et al.
Publicado: (2016)

Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy
por: Ecke, Thorsten H., et al.
Publicado: (2020)

The timing of radical cystectomy following neoadjuvant chemotherapy
por: Ramakrishnan, Venkat M., et al.
Publicado: (2018)

Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical Cystectomy
por: Cantó, Elisabet, et al.
Publicado: (2021)

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy
por: Boström, P.J., et al.
Publicado: (2016)

Extent of lymphadenectomy in radical cystectomy for bladder cancer
por: Ather, M Hammad, et al.
Publicado: (2005)

Editorial: Radical cystectomy in bladder cancer patients
por: Koshkin, Vadim S., et al.
Publicado: (2022)

Cost-Effectiveness of Robot-Assisted Radical Cystectomy vs Open Radical Cystectomy for Patients With Bladder Cancer
por: Dixon, Simon, et al.
Publicado: (2023)

The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study
por: Wahafu, Wasilijiang, et al.
Publicado: (2019)

Radical Cystectomy and Orthotopic Bladder Substitution Using Ileum
por: Park, Jinsung, et al.
Publicado: (2011)

Patterns of recurrence of bladder carcinoma following radical cystectomy
por: Koh, D. M., et al.
Publicado: (2015)

Immediate Radical Cystectomy for Massive Bleeding of Bladder Cancer
por: Cochetti, Giovanni, et al.
Publicado: (2015)

Robot-Assisted Radical Cystectomy in the Management of Bladder Cancer
por: Keim, Jessica L., et al.
Publicado: (2006)

Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs
por: Morii, Yasuhiro, et al.
Publicado: (2019)

Cost-utility analysis of robotic-assisted radical cystectomy for bladder cancer compared to open radical cystectomy in the United Kingdom
por: Machleid, Felix, et al.
Publicado: (2022)

Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesia
por: Gerullis, Holger, et al.
Publicado: (2017)

Neoadjuvant Therapy Using Checkpoint Inhibitors before Radical Cystectomy for Muscle Invasive Bladder Cancer: A Systematic Review
por: SHSM, Hadi, et al.
Publicado: (2021)

The effect of neoadjuvant chemotherapy among patients undergoing radical cystectomy for variant histology bladder cancer: A systematic review
por: Alvarez-Maestro, Mario, et al.
Publicado: (2021)

Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy
por: Ferro, Matteo, et al.
Publicado: (2021)

miR‐199a‐3p and miR‐214‐3p improve the overall survival prediction of muscle‐invasive bladder cancer patients after radical cystectomy
por: Ecke, Thorsten H., et al.
Publicado: (2017)

Radical cystectomy for bladder cancer: A single center experience
por: Gupta, Narmada P., et al.
Publicado: (2008)

Risk groups in bladder cancer patients treated with radical cystectomy
por: Mallen, Eva, et al.
Publicado: (2015)

Decreasing Non–bladder-cancer Mortality After Radical Cystectomy
por: Froehner, Michael, et al.
Publicado: (2021)

Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
por: Schmidt, Bogdana, et al.
Publicado: (2022)

Radical Cystectomy for Intradiverticular Bladder Carcinoma: A Case Report
por: Sah, Anil Kumar, et al.
Publicado: (2021)

Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients
por: Hamid, Agus Rizal A. H., et al.
Publicado: (2020)

Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy
por: Alvaeus, Julia, et al.
Publicado: (2019)

Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Rydell, Harriet, et al.
Publicado: (2022)

Prevalence of Clostridium Difficile Infection in Patients After Radical Cystectomy and Neoadjuvant Chemotherapy
por: Cotter, Katherine J., et al.
Publicado: (2017)

Erratum: Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy
por: Laajala, Teemu D., et al.
Publicado: (2017)

Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy
por: Laajala, Teemu D., et al.
Publicado: (2016)

Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis
por: Cai, Zhiyong, et al.
Publicado: (2021)

Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Comparison of trimodality therapy and neoadjuvant chemotherapy combined with radical cystectomy for the survival of muscle-invasive bladder cancer: a population-based analysis
por: Zhou, Yi-Xin, et al.
Publicado: (2023)

Effect of neoadjuvant chemotherapy on survival in patients with T1 high-grade non-muscle-invasive bladder cancer who underwent radical cystectomy
por: Huang, Long, et al.
Publicado: (2023)

Is radical cystectomy mandatory in every patient with variant histology of bladder cancer
por: Shapur, Nandakishore Kamalakar, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_92idp5p2pk0oe9vngtl0f9nc63